IonQ Shorts Rebuild Fast With Earnings a Week Away

IonQ is a quantum computing company with a $14 billion market cap, a Q3 earnings date of November 4, and a short position that just grew by 16% in a single week. The stock closed at $32.95 on October 27, up 7% on the day and 5.4% on the week, yet that rebound is happening against a backdrop of accelerating short-seller conviction.

Short interest climbed to 13.3% of free float, up from around 10% at the start of October, and the weekly increase of 15.6% is roughly two standard deviations above IonQ's typical weekly move over the past year. That pace of accumulation stands out. Borrow availability has tightened sharply at the same time, falling 33% week-on-week to 11.7%, meaning there are now fewer than twelve shares available to borrow for every hundred already lent out. The 52-week low availability reading is 0.1%, so the lending pool is not yet exhausted, but the direction is clear. Cost to borrow remains low at 1.26%, up 34% over the past month but still far from the levels that would signal a genuine squeeze. The options market is slightly more defensive than usual: the put/call ratio at 0.89 is modestly above its 20-day average of 0.86, with a z-score of 0.9, not an alarm, but pointing in the same direction as the short-side positioning. The ORTEX short score of 65.8 places IonQ in the bottom 6th percentile of its universe on that measure, a ranking that reflects both the level and the recent rate of change. Positioning, taken together, looks charged rather than complacent ahead of next week's print.

The Street remains broadly constructive, even as targets have been trimmed. Morgan Stanley lowered its price target to $43 from $49 on October 15 while holding an Equal-Weight rating, and Rosenblatt cut from $100 to $70 on the same day while keeping a Buy. B of A Securities initiated coverage in late September with a Buy and a $60 target. Wedbush, Needham, and Cantor Fitzgerald all reiterate positive ratings with targets ranging from $65 to $75. The consensus mean target is $64.06, which is nearly double the current price of $32.95 and warrants a note of caution: this gap suggests the Street is either pricing in a substantial re-rating or some of those estimates predate the stock's 28% decline over the past month. The bull case centres on a $1.8 billion cash position, no debt, and standalone 2026 revenue guidance of $280 million to $290 million, with total sales including the acquired Elisity cybersecurity business forecast at $450 million to $460 million. Bears point to the dilutive weight of ten acquisitions since late 2024, limited recurring revenue, customer concentration, and a low-margin foundry business that now makes up a meaningful slice of the guide. EPS surprise ranks in the 96th percentile of the company's universe, and analyst recommendation divergence ranks at the 91st percentile, both unusual for a pre-profitability name. The price-to-book multiple has contracted sharply, down 2.3 points over the past 30 days to 3.3x, tracking the share price fall.

Retail attention has picked up alongside the shorts. Wikipedia page views for IonQ carry a z-score of 2.7 against the company's own 90-day history, a level of retail interest that sits well above the recent norm. That is an attention signal, not a revenue indicator, but it does suggest the upcoming earnings date is generating wider interest than usual for a company of this stage.

Among close peers, RGTI rose 6.7% on the week and KOPN gained 9.6%, both broadly in line with IonQ's 5.4%. The quantum and advanced-semiconductor names moved together. BlackRock filed a Schedule 13G/A on October 27, disclosing a stake of 4.6%, down from 5.3% previously. No 13D activists are on the register. Morgan Stanley holds 5.6% on a passive 13G basis, up from 4.8% at the prior filing. Institutional breadth across 227 holders is reasonable for a name of this market cap, though the absence of any large active manager building a fresh position is notable given the scale of the price decline.

Q3 results arrive on November 4. The one number worth tracking between now and then is availability in the lending pool: if it tightens further toward the low single digits, the cost to borrow will follow, and a week-long 7% recovery in the shares would start to look uncomfortable for a short base that just grew at twice its normal pace.